Effects of Dopamine and Alpha-2 Adrenoreceptor Blockade on L-Dopa and Cholecystokinin-Induced Gastroprotection

Journal of Gastrointestinal Surgery

Volumn 1, Issue 3, 1997, Pages 257-265

  Cross, James M ^a   Mercer, David W ^a   Gunter, Jeffrey ^a   Miller, Thomas A ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347936229     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(97)80118-7     Document Type: Article

References (31)

1. Strang R. The association of gastro-duodenal ulceration and Parkinson's disease. Med J Aust 1965;1:842-843.
2. Szabo S. Dopamine disorder in duodenal ulceration. Lancet 1979;2:880-882.
3. Glavin GB, Szabo S. Dopamine in gastrointestinal disease. Dig Dis Sci 1990;35:1153-1161.
4. MacNaughton WK, Wallace JL. A role for dopamine as an endogenous protective factor in the rat stomach. Gastroenterology 1989;96:972-980.
5. Sikirić P, Rotkvić, I, Miše S, Križanac Š, Gjuriš V, Jukić J, Suchanek E, Petek M, Udovičić I, Kalogjera L, Geber J, Tućan-Foretić M, Duvnjak M, Philipp M, Balen I, Anić T. The influence of dopamine agonist and antagonist on indomethacin lesions in stomach and small intestine in rats. Eur J Pharmacol 1988;158:61-67.
6. Glavin GB, Dugani AM. Effects of dopamine agonists and antagonists on gastric acid secretion and stress responses in rats. Life Sci 1987;41:1397-1408.
7. Szabo S, Neumeyer J. Dopamine agonists and antagonists in duodenal ulcer disease. In Kaiser C, Kebabian J, eds. Dopamine Receptors. Washington, D.C.: American Chemical Society, 1983, pp 175-196.
8. Takeuchi K, Nishiwaki H, Okabe S. Effects of dopamine on gastric mucosal lesions induced by ethanol in rats. Dig Dis Sci 1988;33:1560-1568.
9. Sikirić P, Geber J, Ivanocić D, Suchanek E, Gjuriš V, Tućan-Foretić M, Miše S, Cvitanović B, Rotkvić I. Dopamine antagonists induce gastric lesions in rats. Eur J Pharmacol 1986; 131:105-109.
10. 3H-L-dopa by the rat gut in vivo; evidence for glucuronide conjugation. Biochem Pharmacol 1975;24:1167-1174.
11. Willems J, Buylaert W, Lefebvre R, Bogaert M. Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system. Pharmacol Rev 1985;37:165-216.
12. Kebabian J, Calne D. Multiple receptors for dopamine. Nature 1979;277:93-96.
13. Stoof J, Kebabian J. Two dopamine receptors: Biochemistry, physiology and pharmacology. Life Sci 1984;35:2281-2296.
14. Glavin GB. Dopamine and gastroprotection: The brain-gut axis. Dig Dis Sci 1991;36:1670-1672.
15. 2-adrenoreceptor. Pharmacol Rev 1983;35:143-180.
16. Mercer DW, Cross JM, Barreto JC, Nathaniel HP, Strobel BS, Russell DH, Miller TA. Cholecystokinin is a potent protective agent against alcohol-induced gastric injury in the rat: Role of endogenous prostaglandins. Dig Dis Sci 1995;40: 651-660.
17. Seroogy K, Ceccatelli S, Schalling M, Hökfelt T, Frey P, Walsh J, Dockray G, Brown J, Buchan A, Goldstein M. A subpopulation of dopaminergic neurons in rat ventral mesencephalon contains both neurotensin and cholecystokinin. Brain Res 1988;455:88-98.
18. Keast JR. Muscosal innervation and control of water and ion transport in the intestine. Rev Physiol Biochem Pharmacol 1987;109:1-59.
19. 2 adrenoreceptors in the prevention of gastric injury by ethanol. Am Coll Surg 1990;41:140-142.
20. Karnovsky MJ. A formaldehyde gluteraldehyde fixative of high osmolality for use in electron microscopy. J Cell Biol 1965;27:137A-138A.
21. Schmidt KL, Henagan JM, Smith GS, Hilburn PJ, Miller TA. Prostaglandin cytoprotection against ethanol-induced injury in a rat: A histologic and cytologic study. Gastroenterology 1985;88:649-659.
22. Mercer DW, Klem K, Cross JM, Smith GS, Cashman M, Miller TA. Cholecystokinin induced protection against gastric injury is independent of endogenous somatostatin. Am J Physiol 1996;271:6692-6700.
23. Bogaert MG, Buylaert WA, Lefebvre RA, Willems JL. Peripheral dopamine receptors. In Poste G, Crooke ST, eds. Dopamine Receptor Antagonists. New York: Plenum, 1984, pp 139-155.
24. 2 agonists and antagonists on experimental gastric lesions and gastric acid secretion. J Pharmacol Exp Ther 1989;251:726-730.
25. 2-adrenergic and specific dopamine receptors. J Clin Invest 1982;69:1008-1016.
26. Ruggeri M, Ungerstedt U, Agnati LF, Mutt V, Härfstrand A, Fuxe K. Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbes using intracerebral dialysis in the anaesthetized rat. Neurochem Int 1987;10:509-520.
27. AMA Division of Drugs. Drugs used in extrapyramidal movement disorders. AMA Drug Evaluations 1983, 5th ed., pp 329-351.
28. Valenzuela JE. Dopamine as a possible neurotransmitter in gastric relaxation. Gastroenterology 1976;71:1019-1022.
29. Mersereau WA, Hinchey EJ. Role of gastric mucosal folds in formation of focal ulcers in the rat. Surgery 1982;91:150-155.
30. Reisberg J, Kullmann R. Characterization of vascular dopamine receptors in the gastric circulation of the rabbit. J Cardiovasc Pharmacol 1986;8:1067-1073.
31. Ritchie WP, Mercer DW. Mediator of bile acid-induced alterations in gastric mucosal blood flow. AmJ Surg 1991;161: 126-130.